Tue, Mar 18, 8:31 PM (40 days ago)
**Jackson Acquisition Company II (JACS)** **Financial Performance:** - **Revenue:** No revenue generated from operations; non-operating income from interest on marketable securities held in the Trust Account. - **Net Income:** $381,082 for the period from September 11, 2024, through December 31, 2024. - **Operating Expenses:** $177,396 for the period from September 11, 2024, through December 31, 2024. - **Earnings per Share (EPS):** $0.04 for both basic and diluted net income per ordinary share for Class A and Class B ordinary shares. **Strategic Overview:** - **Business Objective:** To effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. - **Focus:** High-quality businesses in healthcare services, healthcare technology, or otherwise focused on the healthcare industry. - **Funding:** Cash from the proceeds of the IPO, securities, debt, or a combination of these. **Future Outlook:** - **Business Combination:** Must be completed within 24 months from the closing of the IPO (December 11, 2026). - **Redemption Rights:** Public shareholders can redeem their shares upon completion of the business combination or if the company fails to complete it within the specified time frame. - **Financial Condition:** As of December 31, 2024, the company had $232,858,478 in investments held in the Trust Account and $949,366 in cash outside the Trust Account. **Risk Factors:** - **Market Risks:** Volatility and disruption in global markets due to geopolitical instability. - **Operational Risks:** Dependence on the success of identifying and completing a business combination. - **Financial Risks:** Potential dilution of public shareholders' interests and the risk of not completing a business combination within the specified time frame. **Market Position Changes:** - **Trading Symbols:** JACS.U, JACS, and JACS.R on the NYSE. - **Shareholders:** As of March 18, 2025, 23,840,000 Class A ordinary shares and 5,750,000 Class B ordinary shares issued and outstanding. **Ticker:** JACS